No Data
No Data
SABCS 2024: New Research Assesses ICAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
ICAD Presents Next-Generation AI Solutions And A Second-Read AI Partnership With Cascaid Health At RSNA 2024
Express News | ICAD Advances Fight Against Breast Cancer With FDA-Cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at Rsna 2024
Colliers Securities Initiates ICAD Inc(ICAD.US) With Buy Rating, Announces Target Price $3
Need To Know: Analysts Just Made A Substantial Cut To Their ICAD, Inc. (NASDAQ:ICAD) Estimates
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Unlock the Full List